Drug Profile
Gallic acid
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source; Nonindustrial sources; Tokyo Kasei Kogyo
- Developer Nonindustrial source; Tokyo Kasei Kogyo
- Class Antineoplastics; Hydroxybenzoic acids
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Nov 2003 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 14 Nov 2003 Discontinued - Preclinical for Cancer in Singapore (unspecified route)
- 14 Nov 2003 Discontinued - Preclinical for Cancer in USA (unspecified route)